| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 4,488,000 | 4,773,000 | 4,817,000 | 4,852,000 | | Cost of Revenue | 507,000 |
-
| (9,061,000) | 8,595,000 | | | Gross Profit | 3,981,000 | 4,773,000 | 13,878,000 | (3,743,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,515,000 | 4,532,000 | 14,218,000 | (3,975,000) | | Non Recurring | (164,000) | (32,000) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 630,000 | 273,000 | (340,000) | 232,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 630,000 | 273,000 | (340,000) | 232,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 630,000 | 273,000 | (340,000) | 232,000 | | Income Tax Expense | 195,000 | 65,000 | (130,000) | 62,000 | | Minority Interest | (1,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 434,000 | 208,000 | (210,000) | 170,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,000 | 1,000 | 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 434,000 | 209,000 | (209,000) | 171,000 | | Preferred Stock And Other Adjustments | 1,000 | (1,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $435,000 | $208,000 | ($209,000) | $171,000 |
|
0.17% Nasdaq 
Income Statement
